AleksandrTeplitskiy

Mid term swing opportunity in CTI BioPharma (CTIC)

看多
NASDAQ:CTIC   None
Stock had decent drop right after earnings to the lowest channel support line.
Stock is heavily short : 20% of float is short
80% Institutional investors.
nice swing opportunity for a re-bounce to the upper "resistance" channel line.
NASDAQ:CTIC
免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。